These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35677737)

  • 1. When Blood Is Being Difficult: Clotting and Bleeding in a Patient With Antiphospholipid Antibody Syndrome and Supratherapeutic International Normalized Ratio.
    Tiperneni R; Tayyeb M; Fichadiya H; Al-Alwan A; Khalid F; Rajamohan A
    Cureus; 2022 Jun; 14(6):e25659. PubMed ID: 35677737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Difficult and Rare Case of Warfarin Refractory Antiphospholipid Syndrome Presenting With Catastrophic Antiphospholipid Syndrome Complicated by Gastrointestinal Bleeding.
    Lim W; Kaur A; Munoh Kenne F; Shulimovich M
    Cureus; 2021 Aug; 13(8):e17106. PubMed ID: 34527491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
    Dufrost V; Wahl D; Zuily S
    Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Disease in Antiphospholipid Syndrome.
    Polytarchou K; Varvarousis D; Manolis AS
    Curr Vasc Pharmacol; 2020; 18(6):538-548. PubMed ID: 31530257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Venous Thrombosis and Pulmonary Embolism: Current Therapy.
    Wilbur J; Shian B
    Am Fam Physician; 2017 Mar; 95(5):295-302. PubMed ID: 28290648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of acute symptomatic deep vein thrombosis.
    Heit JA
    Am J Cardiovasc Drugs; 2001; 1(1):45-50. PubMed ID: 14728051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Antiphospholipid Syndrome.
    Ghembaza A; Saadoun D
    Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33212808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living donor renal transplantation in patients with antiphospholipid syndrome: A case report.
    Choi JY; Jung JH; Shin S; Kim YH; Han DJ
    Medicine (Baltimore); 2016 Nov; 95(46):e5419. PubMed ID: 27861383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).
    Woller SC; Stevens SM; Kaplan DA; Branch DW; Aston VT; Wilson EL; Gallo HM; Johnson EG; Rondina MT; Lloyd JF; Evans RS; Elliott CG
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):239-47. PubMed ID: 26566669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DVT and pulmonary embolism: Part II. Treatment and prevention.
    Ramzi DW; Leeper KV
    Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.
    Prins MH; Lensing AW; Brighton TA; Lyons RM; Rehm J; Trajanovic M; Davidson BL; Beyer-Westendorf J; Pap ÁF; Berkowitz SD; Cohen AT; Kovacs MJ; Wells PS; Prandoni P
    Lancet Haematol; 2014 Oct; 1(1):e37-46. PubMed ID: 27030066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.
    Ordi-Ros J; Sáez-Comet L; Pérez-Conesa M; Vidal X; Riera-Mestre A; Castro-Salomó A; Cuquet-Pedragosa J; Ortiz-Santamaria V; Mauri-Plana M; Solé C; Cortés-Hernández J
    Ann Intern Med; 2019 Nov; 171(10):685-694. PubMed ID: 31610549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of acute myelogenous leukemia characterized by arterial and venous thrombosis.
    Liang H; Ba M; Li C; Li H; Guo Z; He P; Lin C
    Cardiovasc Diagn Ther; 2020 Oct; 10(5):1332-1340. PubMed ID: 33224757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.
    Ahmed S; Karim A; Patel D; Siddiqui R; Mattana J
    Am J Med Sci; 2002 Nov; 324(5):279-80. PubMed ID: 12449450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
    Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
    Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis against venous thromboembolism in orthopedic surgery.
    Liu LT; Ma BT
    Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with rivaroxaban for an acute pulmonary thromboembolism in a patient with primary antiphospholipid antibody syndrome.
    Okamura G; Kawano H; Yoshida N; Koga S; Ikeda S; Ichinose K; Maemura K
    J Cardiol Cases; 2020 Feb; 21(2):79-81. PubMed ID: 32042361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.